Skip to main content
Year archive

InnoCare Pharma Limited — 2020 filings

All 37 regulatory filings released by InnoCare Pharma Limited (9969) in 2020, sourced directly from the official regulator.

37 Filings
2020 Period
2020 filings (37)
Filing Released Lang
INSIDE INFORMATION ANNOUNCEMENT THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION GRANTED MARKETING APPROVAL FOR ORELABRUTINIB IN CHINA
Regulatory Filings
2020-12-28 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2020
Regulatory Filings
2020-12-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020
Regulatory Filings
2020-11-03 English
VOLUNTARY ANNOUNCEMENT - THE US FOOD AND DRUG ADMINISTRATION CLEARANCE OF PHASE II CLINICAL TRIAL USING ORELABRUTINIB FOR THE TREATMENT OF MULTIPLE SCLEROSIS
Regulatory Filings
2020-11-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2020
Regulatory Filings
2020-10-06 English
INTERIM REPORT 2020
Regulatory Filings
2020-09-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2020
Regulatory Filings
2020-09-02 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2020
Regulatory Filings
2020-08-21 English
DATE OF BOARD MEETING
Regulatory Filings
2020-08-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2020
Regulatory Filings
2020-08-04 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2019
Regulatory Filings
2020-07-22 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2020
Regulatory Filings
2020-07-07 English
ADOPTION OF RESTRICTED SHARE UNIT SCHEME
Regulatory Filings
2020-07-06 English
VOLUNTARY ANNOUNCEMENT APPOINTMENT OF CHIEF COMMERCIAL OFFICER
Regulatory Filings
2020-06-29 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 22, 2020
Regulatory Filings
2020-06-22 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2020
Regulatory Filings
2020-06-04 English
FORM OF PROXY FOR ANNUAL GENERAL MEETING
Regulatory Filings
2020-05-21 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2020-05-21 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS, RE-APPOINTMENT OF AUDITORS AND NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2020-05-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2020
Regulatory Filings
2020-05-06 English
ANNUAL REPORT 2019
Regulatory Filings
2020-04-24 English
Next Day Disclosure Return
Regulatory Filings
2020-04-23 English
FULL EXERCISE OF THE OVER-ALLOTMENT OPTION,STABILIZING ACTIONS AND END OF STABILIZATION PERIOD
Regulatory Filings
2020-04-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2020
Regulatory Filings
2020-04-06 English
List of Directors and their Roles and Functions
Regulatory Filings
2020-03-19 English
Terms of Reference for the Compensation Committee
Regulatory Filings
2020-03-19 English
Terms of Reference for the Nomination Committee
Regulatory Filings
2020-03-19 English
Terms of Reference for the Audit Committee
Regulatory Filings
2020-03-19 English
Amended and Restated Memorandum and Articles of Association
Regulatory Filings
2020-03-19 English
Announcement of Offer Price and Allotment Results
Regulatory Filings
2020-03-19 English
GREEN APPLICATION FORM
Regulatory Filings
2020-03-10 English
YELLOW APPLICATION FORM
Regulatory Filings
2020-03-10 English
WHITE APPLICATION FORM
Regulatory Filings
2020-03-10 English
GLOBAL OFFERING
Regulatory Filings
2020-03-10 English
GLOBAL OFFERING
Regulatory Filings
2020-03-10 English
PHIP (1st submission)
Audit Report / Information FY 2019
2020-03-01 English
PHIP (1st submission)
Regulatory Filings
2020-03-01 English